Campaigns. It is important that I continue to know the strength of feeling on an issue and I prefer to respond to every inquiry, but the sheer size of campaign correspondence means that it is hard to justify to the tax payer the cost and time taken for individual written replies, so regrettably I will no longer reply to every item of campaign correspondence.  I will  post a response to the campaign on the "Responses to campaigns" page of my website.

I am sorry to do this, as it is rather impersonal, but can see no other way of maintaining a good service for all my constituents unless I approach campaigns this way.


10 OCT 2017

EDM 66 and Animal Testing

Thank you for taking the time to email me about EDM 66 and animal testing.

I understand you would like me to sign EDM 66, however like many MPs I do not sign any EDMs no matter how worthy the cause. This is because EDMs now cost a huge amount per year to administer and have no chance of changing the Law. They are in effect petitions which only MPs can sign. They have also been superseded by online petitions which can be on any issue for which the Government or Parliament is responsible and any which receive 10,000 signatures will receive a response from the Government. Those petitions which reach 100,000 signatures will almost always be debated in Parliament – unless it is an issue which has recently been debated. There are also concerns that EDMs may give a false impression that action is being taken.

Nonetheless, please be assured that I agree that animal testing should be kept to a minimum and only under strictly controlled conditions.

I hope you will find the following information on this topic from the Department for Business, Energy and Industrial Strategy of interest:

The carefully regulated use of animals in scientific research remains a vital tool in improving the understanding of how biological systems work and in the development of safe new medicines, treatments and technologies.
At the same time, animals should only be used when there is no practicable alternative and the support and funding for the development and dissemination of techniques that replace, reduce and refine the use of animals in research (the 3Rs) is welcomed.
Without animal testing, it is considered highly likely that a large number of potentially dangerous new medicines would be tested in healthy volunteers and patients in clinical trials. However, encouraging new cutting-edge approaches to science will ensure that standards of animal welfare are improved.

Advances in biomedical science and technologies are all providing new opportunities to reduce reliance on the use of animals in research. As part of this, a Non-animal Technologies Road map for the UK has been produced which offers an approach for the UK to develop, exploit and deploy new non-animal technologies for long-term economic and societal benefit.
The EDM rightly draws attention to the UK life science sector's Concordat on Openness in Animal Research which was launched in 2014, and it provides new opportunities for transparency and debate in this area. Ultimately, however, EU and UK law requires safety testing on animals before human trials for new medicines can begin and animal research still plays an important role in providing vital safety information for potential new medicines.

Back to all posts